Key result
Combining Src inhibition with Tie2 activation is predicted to reduce vascular leakage without blocking angiogenesis.
Why the study?
In peripheral arterial disease, vascular permeability challenges therapeutic efforts to improve perfusion, requiring mechanistic understanding of endothelial signaling to permit vessel growth while maintaining stability.
Does combining Src inhibition with Tie2 activation reduce vascular leakage without disturbing angiogenesis signaling in an endothelial cell model?
Does combining Src inhibition with Tie2 activation reduce vascular leakage without disturbing angiogenesis signaling in an endothelial cell model?
A computational systems biology model predicts that combining Src inhibition with Tie2 activation can suppress vascular permeability while maintaining angiogenic signaling, offering a potential therapeutic strategy for peripheral arterial disease.
No takes yet. Share an insight, caveat, or question.
May inform endothelial permeability models; leaves open in vivo validation for peripheral arterial disease.
Zhang et al. (2025) studied Angiogenesis-related diseases (Peripheral arterial disease, cancer, ocular diseases). Src inhibition combined with Tie2 activation (Ang1) vs. VEGF stimulation alone or Ang1 alone was evaluated on Src activation and vascular permeability. A computational systems biology model predicts that combining Src inhibition with Tie2 activation reduces vascular leakage without blocking angiogenesis signaling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: